We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$2.29B
AUM Growth
+$308M
Cap. Flow
+$128M
Cap. Flow %
5.6%
Top 10 Hldgs %
38.21%
Holding
106
New
19
Increased
26
Reduced
11
Closed
11

Top Buys

Rank Stock Value
1
XPER icon
Xperi
XPER
+$44M
2
NFE icon
New Fortress Energy
NFE
+$40.7M
3
ARQT icon
Arcutis Biotherapeutics
ARQT
+$39.7M
4
HRTX icon
Heron Therapeutics
HRTX
+$29.7M
5
ZYME icon
Zymeworks
ZYME
+$21.2M

Top Sells

Rank Stock Value
1
ADEA icon
Adeia
ADEA
+$101M
2
APO icon
Apollo Global Management
APO
+$44.2M
3
GSM icon
FerroAtlántica
GSM
+$36.1M
4
GPRE icon
Green Plains
GPRE
+$29.8M
5
HTZ icon
Hertz
HTZ
+$18.2M

Sector Composition

Rank Sector Weight
1 Healthcare 27.49%
2 Energy 19.6%
3 Industrials 18.17%
4 Technology 7.38%
5 Financials 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
26
Heron Therapeutics
HRTX
$62.7M
$29.4M 1.28%
11,750,000
+9,233,672
+367% +$29.7M
KPTI icon
27
Karyopharm Therapeutics
KPTI
$45.3M
$28.2M 1.23%
552,975
+286,967
+108% +$19.9M
AMYT
28
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$26.3M 1.15%
3,600,000
– –
STRO icon
29
Sutro Biopharma
STRO
$360M
$26M 1.13%
321,187
+181,187
+129% +$12.6M
SPRY icon
30
ARS Pharmaceuticals
SPRY
$613M
$25.5M 1.11%
2,990,564
+295,394
+11% +$1.92M
BHC icon
31
Bausch Health
BHC
$2.34B
$25.5M 1.11%
4,052,945
+788,474
+24% +$5.51M
ROIV icon
32
Roivant Sciences
ROIV
$26.2B
$24M 1.05%
+3,000,000
New +$16.7M
ZYME icon
33
Zymeworks
ZYME
$1.84B
$23.7M 1.03%
+3,018,217
New +$21.2M
KNSA icon
34
Kiniksa Pharmaceuticals
KNSA
$6.08B
$23.5M 1.03%
1,569,503
+123,396
+9% +$1.8M
DMRC icon
35
Digimarc Corp
DMRC
$165M
$22.5M 0.98%
1,214,593
– –
QNST icon
36
QuinStreet
QNST
$1.19B
$19.5M 0.85%
1,360,683
– –
KDNY
37
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$18.9M 0.82%
719,809
-229,357
-24% -$5.08M
SDGR icon
38
Schrodinger
SDGR
$1.37B
$18.7M 0.81%
1,000,000
-77,621
-7% -$1.61M
EVER icon
39
EverQuote
EVER
$875M
$18.4M 0.8%
1,246,622
– –
MX icon
40
Magnachip Semiconductor
MX
$138M
$18.3M 0.8%
1,950,100
– –
CCO icon
41
Clear Channel Outdoor Holdings
CCO
$1.18B
$18.3M 0.8%
17,391,427
– –
HRT
42
DELISTED
HireRight Holdings Corporation
HRT
$18.1M 0.79%
1,523,266
– –
META icon
43
Meta Platforms (Facebook)
META
$1.52T
$16.1M 0.7%
+133,465
New +$15.7M
ANIP icon
44
ANI Pharmaceuticals
ANIP
$1.71B
$15.1M 0.66%
376,132
+89,086
+31% +$3.35M
IDCC icon
45
InterDigital
IDCC
$8.96B
$15.1M 0.66%
+304,260
New +$14.8M
CMRX
46
DELISTED
Chimerix, Inc.
CMRX
$13.9M 0.61%
7,500,000
+875,000
+13% +$1.71M
GOOG icon
47
Alphabet (Google) Class C
GOOG
$4.21T
$13.5M 0.59%
+152,315
New +$14.5M
PNT
48
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$13.3M 0.58%
+1,827,304
New +$13.6M
OVID icon
49
Ovid Therapeutics
OVID
$517M
$12.7M 0.55%
6,828,065
+2,311,765
+51% +$3.94M
RNW icon
50
ReNew
RNW
$2.48B
$12.5M 0.55%
2,279,013
– –
1
2
3 4 5

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return
TCA
Tortoise Capital Advisors Overland Park, Kansas $9.6B AUM 19.53% 1-Year Est. Return

Rubric Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Rubric Capital Management (New York) held 106 positions worth $2.29B, up 16% from $1.99B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rubric Capital Management (New York) deployed $128M of net new capital in Q4 2022, opening 19 new positions and adding to 26 existing holdings. Its largest new stake was Xperi: 3,843,744 shares worth $33.1M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 23% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Adeia, an estimated $101M trimmed.

  • Rubric Capital Management (New York)'s largest Q4 2022 buy was Xperi: 3,843,744 shares worth $33.1M.
  • Rubric Capital Management (New York) added most to New Fortress Energy in Q4 2022, an estimated $40.7M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2022 reduction was Adeia, cutting an estimated $101M.
  • Rubric Capital Management (New York) fully exited Apollo Global Management in Q4 2022, selling an estimated $44.2M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $2.29B portfolio in Q4 2022.
  • Rubric Capital Management (New York) opened 19 new positions and closed 11 in Q4 2022.
  • Rubric Capital Management (New York)'s portfolio value rose 16% quarter-over-quarter to $2.29B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2022, filed 10 Feb 2023.